Skip to main content

Contact

Home
About
Products
Newsroom
Careers
Contact

PMG1015 Demonstrates a Well-Tolerated Safety Profile and Favorable FVC Changes after 12 Weeks of Treatment in IPF Patients

Science

18 November 2025

This article is hosted externally.

SHARE ARTICLE

Qureight operates a management system certified to ISO 13485:2016 and ISO 27001:2022. The Qureight Platform is GxP and 21 CFR Part 11 compliant. Further information on quality and compliance can be found in our Trust Centre.

Enterprise-grade imaging and
precision endpoints for clinical trials

Qureight Ltd
50 - 60 Station Road
Cambridge
CB1 2JH
UK
Company registration number: 11132399
Company VAT number: 352310245

Home
About
Newsroom
Contact
Trust Centre

Copyright © 2026 Qureight